| NCT Number | NCT06972667 |
| Lead Sponsor | State University of New York at Buffalo
Collaborators: National Cancer Institute (NCI) |
| Conditions | Health Information Avoidance |
| Enrollment | 1,500 participants |
| Start Date | 2025-12-10 |
| Primary Completion | 2026-09 (estimated) |
| Study Completion | 2026-09 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-04 |